Home › Companies › KINIKSA PHARMACEUTICALS LTD. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and KINIKSA PHARMACEUTICALS LTD.’s Form 8-K, filed June 5, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 5, 2024: 6 items on KINIKSA PHARMACEUTICALS LTD.’s Form 8-K, filed June 5, 2024: 1 approved · 5 passed (calculated).
Significant dissent: 1 director (33.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore KINIKSA PHARMACEUTICALS LTD. in the interactive database Compare manager voting policies
These tallies are KINIKSA PHARMACEUTICALS LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Felix J. Baker, Ph.D. | 31,885,339 | -- | -- | 15,812,807 | 3,067,059 | 67% | Passed (calculated) | — |
| Elect Director: Tracey L. McCain | 46,746,052 | -- | -- | 952,094 | 3,067,059 | 98% | Passed (calculated) | — |
| Elect Director: Kimberly J. Popovits | 46,745,428 | -- | -- | 952,718 | 3,067,059 | 98% | Passed (calculated) | — |
| 2. The (a) appointment of PricewaterhouseCoopers LLP as the Company's auditor until the close of the Company's next Annual Meeting of Shareholders, (b) delegation to the Company's Board of Directors, through the Audit Committee of the Board of Directors, of th | 50,512,245 | 217,508 | 35,452 | -- | 0 | 99.6% | Passed (calculated) | — |
| 3. The approval, on a non - binding, advisory basis, of the compensation of our named executive officers as disclosed in the Company's proxy statement for the Annual Meeting pursuant to the applicable compensation disclosure rules of the Securities and Exchang | 46,903,551 | 469,616 | 324,979 | -- | 3,067,059 | 99.0% | Approved | — |
| 1. The election of Felix J | 61,460,949 | 501,355 | 274,060 | -- | -- | 99.2% | Passed (calculated) | — |
Source: KINIKSA PHARMACEUTICALS LTD., Form 8-K, filed with the SEC on June 5, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
189 asset managers disclosed a vote on at least one KINIKSA PHARMACEUTICALS LTD. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of KINIKSA PHARMACEUTICALS LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
67% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors to serve until the 2027 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Felix J Baker, Ph.D.
KINIKSA PHARMACEUTICALS LTD.’s own tally for this item (“Elect Director: Felix J. Baker, Ph.D.”): 31,885,339 for, 15,812,807 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 67% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 3,156,023 for, 6,701,599 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,937,249 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 1,901,966 | Withhold |
| State Street | 0 | 0 | 0 | 868,032 | Withhold |
| TIAA | 0 | 0 | 0 | 834,180 | Withhold |
| Fidelity | 0 | 0 | 0 | 484,539 | Withhold |
| Dimensional | 0 | 0 | 0 | 380,376 | Withhold |
| SEI | 0 | 0 | 0 | 296,344 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 238,411 | Withhold |
| MERIDIAN FUND INC | 0 | 0 | 0 | 191,844 | Withhold |
| Jackson National | 0 | 0 | 0 | 144,668 | Withhold |
| Allspring | 0 | 0 | 0 | 121,237 | Withhold |
| Victory Capital | 0 | 0 | 0 | 103,127 | Withhold |
| Equitable | 0 | 0 | 0 | 93,219 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 84,155 | Withhold |
| DWS | 0 | 0 | 0 | 83,435 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 80,854 | Withhold |
| MFS | 0 | 0 | 0 | 78,153 | Withhold |
| Advisors' Inner Circle Fund III | 74,490 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 59,247 | Withhold |
| Prudential/PGIM | 57,600 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 47,116 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 46,669 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 45,636 | Withhold |
| RBB FUND, INC. | 0 | 0 | 0 | 44,566 | Withhold |
| Nationwide | 286 | 0 | 0 | 41,801 | Withhold |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors to serve until the 2027 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Kimberly J. Popovits
KINIKSA PHARMACEUTICALS LTD.’s own tally for this item (“Elect Director: Kimberly J. Popovits”): 46,745,428 for, 952,718 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 9,408,878 for, 448,744 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,937,249 | 0 | 0 | 0 | For |
| BlackRock | 1,901,966 | 0 | 0 | 0 | For |
| State Street | 868,032 | 0 | 0 | 0 | For |
| TIAA | 834,180 | 0 | 0 | 0 | For |
| Fidelity | 484,539 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 380,376 | Withhold |
| SEI | 296,344 | 0 | 0 | 0 | For |
| Goldman Sachs | 238,411 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 191,844 | 0 | 0 | 0 | For |
| Jackson National | 137,928 | 0 | 0 | 6,740 | For |
| Allspring | 121,237 | 0 | 0 | 0 | For |
| Victory Capital | 103,127 | 0 | 0 | 0 | For |
| Equitable | 53,659 | 0 | 0 | 39,560 | Mixed |
| Charles Schwab | 84,155 | 0 | 0 | 0 | For |
| DWS | 83,435 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 80,854 | 0 | 0 | 0 | For |
| MFS | 78,153 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 74,490 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 59,247 | 0 | 0 | 0 | For |
| Prudential/PGIM | 57,600 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 47,116 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,669 | 0 | 0 | 0 | For |
| Lincoln Financial | 41,412 | 0 | 0 | 4,224 | Mixed |
| RBB FUND, INC. | 44,566 | 0 | 0 | 0 | For |
| Nationwide | 42,087 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors to serve until the 2027 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Tracey L. McCain
KINIKSA PHARMACEUTICALS LTD.’s own tally for this item (“Elect Director: Tracey L. McCain”): 46,746,052 for, 952,094 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 9,408,878 for, 448,744 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,937,249 | 0 | 0 | 0 | For |
| BlackRock | 1,901,966 | 0 | 0 | 0 | For |
| State Street | 868,032 | 0 | 0 | 0 | For |
| TIAA | 834,180 | 0 | 0 | 0 | For |
| Fidelity | 484,539 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 380,376 | Withhold |
| SEI | 296,344 | 0 | 0 | 0 | For |
| Goldman Sachs | 238,411 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 191,844 | 0 | 0 | 0 | For |
| Jackson National | 137,928 | 0 | 0 | 6,740 | For |
| Allspring | 121,237 | 0 | 0 | 0 | For |
| Victory Capital | 103,127 | 0 | 0 | 0 | For |
| Equitable | 53,659 | 0 | 0 | 39,560 | Mixed |
| Charles Schwab | 84,155 | 0 | 0 | 0 | For |
| DWS | 83,435 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 80,854 | 0 | 0 | 0 | For |
| MFS | 78,153 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 74,490 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 59,247 | 0 | 0 | 0 | For |
| Prudential/PGIM | 57,600 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 47,116 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,669 | 0 | 0 | 0 | For |
| Lincoln Financial | 41,412 | 0 | 0 | 4,224 | Mixed |
| RBB FUND, INC. | 44,566 | 0 | 0 | 0 | For |
| Nationwide | 42,087 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.6% of fund votes cast · no official result
Description as filed by funds: To approve the Scheme of Arrangement attached to the accompanying proxy statement as Annex A among the Company and its shareholders.
The 70 asset managers below reported 9,800,514 for, 39,223 against, 17,844 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,937,249 | 0 | 0 | 0 | For |
| BlackRock | 1,901,966 | 0 | 0 | 0 | For |
| State Street | 868,032 | 0 | 0 | 0 | For |
| TIAA | 834,180 | 0 | 0 | 0 | For |
| Fidelity | 484,539 | 0 | 0 | 0 | For |
| Dimensional | 380,376 | 0 | 0 | 0 | For |
| SEI | 296,344 | 0 | 0 | 0 | For |
| Goldman Sachs | 238,411 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 191,844 | 0 | 0 | 0 | For |
| Jackson National | 144,668 | 0 | 0 | 0 | For |
| Allspring | 121,237 | 0 | 0 | 0 | For |
| Victory Capital | 103,127 | 0 | 0 | 0 | For |
| Equitable | 93,219 | 0 | 0 | 0 | For |
| Charles Schwab | 84,155 | 0 | 0 | 0 | For |
| DWS | 83,435 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 80,854 | 0 | 0 | 0 | For |
| MFS | 78,153 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 74,490 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 59,247 | 0 | 0 | 0 | For |
| Prudential/PGIM | 57,600 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 7,893 | 39,223 | 0 | 0 | Mixed |
| Direxion Shares ETF Trust | 46,669 | 0 | 0 | 0 | For |
| Lincoln Financial | 45,636 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 44,566 | 0 | 0 | 0 | For |
| Nationwide | 42,087 | 0 | 0 | 0 | For |
Showing the 25 largest of 70 asset managers. All 70 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
87% of fund votes cast · no official result
Description as filed by funds: To approve a motion to adjourn the Special Court-Ordered Meeting of the shareholders of the Company (the "Redomiciliation Meeting") to a later date to solicit additional proxies if there are insufficient proxies to approve the Scheme of Arrangement at the time of the Redomiciliation Meeting.
The 68 asset managers below reported 8,440,698 for, 1,316,292 against, 17,844 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,937,249 | 0 | 0 | 0 | For |
| BlackRock | 1,901,966 | 0 | 0 | 0 | For |
| State Street | 0 | 868,032 | 0 | 0 | Against |
| TIAA | 834,180 | 0 | 0 | 0 | For |
| Fidelity | 67,139 | 417,400 | 0 | 0 | Mixed |
| Dimensional | 380,376 | 0 | 0 | 0 | For |
| SEI | 296,344 | 0 | 0 | 0 | For |
| Goldman Sachs | 238,411 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 191,844 | 0 | 0 | 0 | For |
| Jackson National | 144,668 | 0 | 0 | 0 | For |
| Allspring | 121,237 | 0 | 0 | 0 | For |
| Victory Capital | 103,127 | 0 | 0 | 0 | For |
| Equitable | 93,219 | 0 | 0 | 0 | For |
| Charles Schwab | 84,155 | 0 | 0 | 0 | For |
| DWS | 83,435 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 80,854 | 0 | 0 | 0 | For |
| MFS | 78,153 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 59,247 | 0 | 0 | 0 | For |
| Prudential/PGIM | 57,600 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 47,116 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,669 | 0 | 0 | 0 | For |
| Lincoln Financial | 18,936 | 26,700 | 0 | 0 | Mixed |
| RBB FUND, INC. | 44,566 | 0 | 0 | 0 | For |
| Nationwide | 42,087 | 0 | 0 | 0 | For |
| 1290 Funds | 35,868 | 0 | 0 | 0 | For |
Showing the 25 largest of 68 asset managers. All 68 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
99.0% Approved · of votes cast
Prior year: 97.0% for (June 6, 2023 meeting) ▲ 2.1 pts
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2024 Annual Meeting pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.
KINIKSA PHARMACEUTICALS LTD.’s own tally for this item (“3. The approval, on a non - binding, advisory basis, of the compensation of our named executive officers as disclosed in the Company's proxy statement for the Annual Meeting pursuant to the applicable compensation disclo”): 46,903,551 for, 469,616 against — passed, per its Form 8-K filed June 5, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 was approved.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,937,249 | 0 | 0 | 0 | For |
| BlackRock | 1,901,966 | 0 | 0 | 0 | For |
| State Street | 868,032 | 0 | 0 | 0 | For |
| TIAA | 834,180 | 0 | 0 | 0 | For |
| Fidelity | 484,539 | 0 | 0 | 0 | For |
| Dimensional | 380,376 | 0 | 0 | 0 | For |
| SEI | 296,344 | 0 | 0 | 0 | For |
| Goldman Sachs | 238,411 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 191,844 | 0 | 0 | 0 | For |
| Jackson National | 144,668 | 0 | 0 | 0 | For |
| Allspring | 121,237 | 0 | 0 | 0 | For |
| Victory Capital | 103,127 | 0 | 0 | 0 | For |
| Equitable | 93,219 | 0 | 0 | 0 | For |
| Charles Schwab | 84,155 | 0 | 0 | 0 | For |
| DWS | 83,435 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 80,854 | 0 | 0 | 0 | For |
| MFS | 78,153 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 74,490 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 59,247 | 0 | 0 | 0 | For |
| Prudential/PGIM | 57,600 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 47,116 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,669 | 0 | 0 | 0 | For |
| Lincoln Financial | 45,636 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 44,566 | 0 | 0 | 0 | For |
| Nationwide | 36,233 | 5,854 | 0 | 0 | Mixed |
Fund voting reports, all 69 managers: 9,807,770 for, 29,450 against, 17,844 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 3,204,841 | 0 | 0 | 0 | For |
| HHLR ADVISORS, LTD. | 3,135,735 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 2,799,577 | 0 | 0 | 0 | For |
| BlackRock | 1,700,443 | 8,649 | 0 | 0 | For |
| State Street | 1,497,960 | 327 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,344,336 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 1,159,536 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,034,733 | 0 | 0 | 0 | For |
| Nuveen | 835,359 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 555,469 | 0 | 0 | 0 | For |
| Granahan Investment Management, LLC | 482,190 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 462,198 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 448,394 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 403,318 | 0 | 0 | 0 | For |
| Altitude Crest Partners Inc. | 400,441 | 0 | 0 | 0 | For |
| SEI | 299,025 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 249,542 | 0 | 0 | 0 | For |
| Prudential/PGIM | 205,648 | 3,950 | 0 | 0 | For |
| DE Shaw | 195,950 | 0 | 0 | 0 | For |
| Northern Trust | 174,607 | 0 | 0 | 0 | For |
| Hudson Bay Capital Management LP | 170,621 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 130,246 | 0 | 0 | 0 | For |
| Allianz | 0 | 126,279 | 0 | 0 | Against |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 122,476 | 0 | 0 | 0 | For |
| Allspring | 121,924 | 0 | 0 | 0 | For |
Institutional-manager reports, all 137 managers: 23,446,115 for, 226,014 against, 26 not voted, 7 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Prior year: 100.0% for (June 6, 2023 meeting) ▼ 0.4 pts
Description as filed by funds: The appointment of PricewaterhouseCoopers LLP as the Company's auditor until the close of the Company's next Annual Meeting of Shareholders, the delegation to the Company's Board of Directors, through its Audit Committee, of the authority to set the auditor's remuneration for such period, and the ratification of the appointment of PricewaterhouseCoopers LLP, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
KINIKSA PHARMACEUTICALS LTD.’s own tally for this item (“2. The (a) appointment of PricewaterhouseCoopers LLP as the Company's auditor until the close of the Company's next Annual Meeting of Shareholders, (b) delegation to the Company's Board of Directors, through the Audit Co”): 50,512,245 for, 217,508 against, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 70 asset managers below reported 9,765,247 for, 74,490 against, 17,844 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,937,249 | 0 | 0 | 0 | For |
| BlackRock | 1,901,966 | 0 | 0 | 0 | For |
| State Street | 868,032 | 0 | 0 | 0 | For |
| TIAA | 834,180 | 0 | 0 | 0 | For |
| Fidelity | 484,539 | 0 | 0 | 0 | For |
| Dimensional | 380,376 | 0 | 0 | 0 | For |
| SEI | 296,344 | 0 | 0 | 0 | For |
| Goldman Sachs | 238,411 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 191,844 | 0 | 0 | 0 | For |
| Jackson National | 144,668 | 0 | 0 | 0 | For |
| Allspring | 121,237 | 0 | 0 | 0 | For |
| Victory Capital | 103,127 | 0 | 0 | 0 | For |
| Equitable | 93,219 | 0 | 0 | 0 | For |
| Charles Schwab | 84,155 | 0 | 0 | 0 | For |
| DWS | 83,435 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 80,854 | 0 | 0 | 0 | For |
| MFS | 78,153 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 74,490 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 59,247 | 0 | 0 | 0 | For |
| Prudential/PGIM | 57,600 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 47,116 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 46,669 | 0 | 0 | 0 | For |
| Lincoln Financial | 45,636 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 44,566 | 0 | 0 | 0 | For |
| Nationwide | 42,087 | 0 | 0 | 0 | For |
Showing the 25 largest of 70 asset managers. All 70 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 2,937,249 |
| 2 | BlackRock | 1,901,966 |
| 3 | State Street | 868,032 |
| 4 | TIAA | 834,180 |
| 5 | Fidelity | 484,539 |
| 6 | Dimensional | 380,376 |
| 7 | SEI | 296,344 |
| 8 | Goldman Sachs | 238,411 |
| 9 | MERIDIAN FUND INC | 191,844 |
| 10 | Jackson National | 144,668 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Fairmount Funds Management LLC | 3,204,841 |
| 2 | HHLR ADVISORS, LTD. | 3,135,735 |
| 3 | BAKER BROS. ADVISORS LP | 2,799,577 |
| 4 | BlackRock | 1,709,092 |
| 5 | State Street | 1,498,287 |
| 6 | PICTET ASSET MANAGEMENT SA | 1,344,336 |
| 7 | Rubric Capital Management LP | 1,159,536 |
| 8 | BRAIDWELL LP | 1,034,733 |
| 9 | Nuveen | 835,359 |
| 10 | ArrowMark Colorado Holdings LLC | 555,469 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to KINIKSA PHARMACEUTICALS LTD. for the 2023-2024 season, so there is no denominator to divide by.
At KINIKSA PHARMACEUTICALS LTD.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 189 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,618 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of the named executive officers… — KINIKSA PHARMACEUTICALS LTD.'s filing reports the proposal as approved, with 99.0% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: KINIKSA PHARMACEUTICALS LTD.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
KINIKSA PHARMACEUTICALS LTD. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “KINIKSA PHARMACEUTICALS (KNSA) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/kiniksa-pharmaceuticals-international-plc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.